Work with Us

Spin out Companies

Newcastle University Spin out Companies

We have an excellent track record for producing spin-out companies from applied research with a significant role in the development of new products and services.

Our Spin out companies also contribute to the development and vitality of the region through new jobs and revenue creation.

Advanced Electric Machines

Advanced Electric Machines’ unique, low cost traction motor technology is designed to drive tomorrow's hybrid, range extended and electric commercial vehicles. The technology, designed specifically for commercial vehicles, delivers excellent performance in a robust package.

Aelius Biotech

Aelius Biotech is a contract research company specialising in modelling the mucosal surfaces of the aerodigestive tract. Aelius' Integrated Model Gut System is a lab model stretching from the mouth to the large intestine which can be used to test drug delivery and absorption, screen formulations, develop and test functional foods and study pre- and pro- biotics. Aelius Biotech aim to help customers understand, develop and test formulations at the vital pre-clinical stages.


Alcyomics is a UK based unique pre-clinical service provider using Skimune®, non-artificial human skin explants for safety and efficacy assessment of novel compounds and drugs. Its mission is to provide novel solutions for pre-clinical drug safety and efficacy testing for therapeutics including cellular therapies and to extend its technologies for use in the chemical and cosmetic industries.

AMLo Biosciences

Amlo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify a patient’s true risk of disease progression. AMLo Biosciences has identified two proteins (AMBLor®) in the skin overlying the primary tumour that are lost in high-risk melanoma.

Armatus Oceanics

Armatus Oceanics does underwater technology and deep ocean research. Armatus Oceanic’s continuing mission is to develop and deploy underwater technology to allow the exploration and surveying of up to 11,000 meters below the ocean’s surface.


Atelerix offers a transformative hydrogel technology for the storage and transport of viable cells including stem cells and cell-based assays at ambient temperatures. This overcomes the barriers presented by the current need for cryo-shipping as it is simple, cell-friendly and offers immediate access to stem cell therapies.

3D Biotissues

3D Biotissues (VEO) transplantable corneas using 3D bio-printing. The company is a leading provider of cutting-edge technologies in corneal 3D printing. Founded by Professor Che Connon at Newcastle University, using knowledge of corneal biology gained after 20 years of performing cutting edge research into a fundamental understanding of how the cornea works.


CellulaREvolution’s mission is to be the leader in continuous cell culturing technologies, providing our clients with highly sophisticated and innovative products. The company has expertise in the design and bioactivity testing of peptide-based molecules for biotechnological applications. We have also developed a smart coating, demonstrating the concept of continuous cell manufacture.


Changing Health

Changing Health provides digital services aimed at people suffering from, or at risk of, Type 2 diabetes. It provides access to a range of digital health education articles and interactive activities on diet and exercise along with personal telephone access to a specialist lifestyle behaviour change coach.


Demuris is a drug discovery and development company employing state-of-the-art platform technologies in natural product discovery, design and production. The starting point for Demuris’ portfolio of new drug development often lies in a unique collection of Actinomycete bacteria. These organisms can manipulate the behaviour of surrounding organisms, including bacteria, fungi, plants and animals.


Electrokinetic specialises in provision of slope stabilisation and ground strengthening products and services, employing electrokinetic technologies, principally for the infrastructure and waste reduction markets.


e-Therapeutics plc accelerates drug discovery through a novel view of disease networks.By combining biological expertise and a powerful computer-based platform, the company creates and analyses network models of disease to identify likely proteins that could effectively be disrupted to treat the disease.

Newcells Biotech

Newcells Biotech’s expertise is in the production of induced pluripotent stem cells and their differentiation into a wide range of reliable and reproducible cell and tissue types. The company aims to provide customers engaged in drug discovery, pre-clinical development and disease mechanism investigation, with the best quality cells and services.


Advancing diagnosis, care and treatment for those living with neuromuscular diseases around the world.


We combine decades of research experience with our robust preclinical drug development testbeds to provide world-class research solutions in liver, kidney and lung disease.


Scubatx develops technology to preserve organs. In doing so they offer healthcare providers significant net savings, and so help clinicians around the world to increase the pool of life-giving organs.